JOUNCE THERAPEUTICS INC's ticker is JNCE and the CUSIP is 481116101. A total of 103 filers reported holding JOUNCE THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 0.82 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $273,000 | +145.9% | 40,853 | +282.9% | 0.00% | – |
| Q1 2021 | $111,000 | -89.8% | 10,669 | -92.9% | 0.00% | -100.0% |
| Q4 2020 | $1,086,000 | +7.6% | 150,731 | +38.2% | 0.00% | 0.0% |
| Q3 2020 | $1,009,000 | +34.0% | 109,061 | -7.6% | 0.00% | 0.0% |
| Q2 2020 | $753,000 | +50.9% | 118,074 | +5.5% | 0.00% | 0.0% |
| Q1 2020 | $499,000 | +2395.0% | 111,875 | +4901.1% | 0.00% | – |
| Q4 2019 | $20,000 | +300.0% | 2,237 | +56.1% | 0.00% | – |
| Q3 2019 | $5,000 | -44.4% | 1,433 | -24.5% | 0.00% | – |
| Q2 2019 | $9,000 | +125.0% | 1,898 | +222.2% | 0.00% | – |
| Q1 2019 | $4,000 | +300.0% | 589 | +181.8% | 0.00% | – |
| Q4 2018 | $1,000 | -50.0% | 209 | +2.0% | 0.00% | – |
| Q3 2018 | $2,000 | 0.0% | 205 | -1.4% | 0.00% | – |
| Q2 2018 | $2,000 | – | 208 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Pharmstandard International S.A. | 662,063 | $10,315,000 | 30.07% |
| Omega Fund Management, LLC | 579,650 | $9,031,000 | 5.11% |
| Casdin Capital, LLC | 399,825 | $6,229,000 | 1.76% |
| Cormorant Asset Management, LP | 359,738 | $5,605,000 | 0.99% |
| Foresite Capital Management II, LLC | 119,912 | $1,868,000 | 0.76% |
| Redmile Group, LLC | 955,598 | $14,888,000 | 0.73% |
| PFM Health Sciences, LP | 1,727,997 | $26,922,000 | 0.53% |
| Fosun International Ltd | 285,960 | $4,455,000 | 0.44% |
| Partner Investment Management, L.P. | 14,265 | $222,000 | 0.21% |
| Spark Investment Management LLC | 162,200 | $2,527,000 | 0.14% |